Autolus Reports Full Year 2020 Financial Results

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.

Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy

To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.

	For the Year Ended December 31,				For the three-months ended December 31,		For the Year Ended September 30,
	2020		2019		2018		2018
Grant income	$	1,473	$	2,908	$	296	$	1,407
License revenue	242		-		-		-
Operating expenses:
Research and development	(134,888)		(105,418)		(17,713)		(36,150)
General and administrative	(34,972)		(39,452)		(7,593)		(22,790)
Loss on impairment of leasehold improvements	-		(4,102)		-		-
Total operating expenses, net	(168,145)		(146,064)		(25,010)		(57,533)
Other income (expense):
Interest income	536		2,542		660		1,532
Other income (expense)	1,352		4,514		1,097		3,970
Total other income, net	1,888		7,056		1,757		5,502
Net loss before income tax	(166,257)		(139,008)		(23,253)		(52,031)
Income tax benefit	24,163		15,159		2,605		7,280
Net loss attributable to ordinary shareholders	(142,094)		(123,849)		(20,648)		(44,751)
Other comprehensive (loss) income:
Foreign currency exchange translation adjustment	2,830		6,797		(5,568)		(6,071)
Total comprehensive loss	(139,264)		(117,052)		(26,216)		(50,822)

Basic and diluted net loss per ordinary share	$	(2.76)	$	(2.88)	$	(0.52)	$	(1.42)
Weighted-average basic and diluted ordinary shares	51,558,075		43,065,542		39,366,634		31,557,034

	December 31,
	2020		2019
Assets
Current assets:
Cash	$	153,299	$	210,643
Restricted cash	786		787
Prepaid expenses and other current assets	42,899		37,826
Total current assets	196,984		249,256
Non-current assets:
Property and equipment, net	38,046		28,164
Prepaid expenses and other non-current assets	3,033		-
Right of use asset, net	51,637		23,409
Long-term deposits	2,625		2,040
Deferred tax asset	1,754		410
Intangible assets, net	158		254
Total assets	$	294,237	$	303,533
Liabilities and shareholders' equity
Current liabilities:
Accounts payable	2,263		1,075
Accrued expenses and other liabilities	27,781		21,398
Lease liability	3,590		2,511
Total current liabilities	33,634		24,984
Non-current liabilities:
Lease liability	50,571		23,710
Total liabilities	84,205		48,694

Shareholders' equity:
Ordinary shares, $0.000042 par value; 200,000,000 shares authorized at December 31, 2020 and 2019, 52,346,231 and 44,983,006 shares issued and outstanding at December 31, 2020 and 2019	3		2
Deferred shares, £0.00001 par value; 34,425 shares authorized, issued and outstanding at December 31, 2020 and 2019	-		-
Deferred B shares, £0.00099 par value; 88,893,548 shares authorized, issued and outstanding at December 31, 2020 and 2019	118		118
Deferred C shares, £0.000008 par value; 1 share authorized, issued and outstanding at December 31, 2020 and 2019	-		-
Additional paid-in capital	595,016		500,560
Accumulated other comprehensive loss	(5,861)		(8,691)
Accumulated deficit	(379,244)		(237,150)
Total shareholders' equity	210,032		254,839
Total liabilities and shareholders' equity	$	294,237	$	303,533

Companies

UK 100

Latest directors dealings